HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Goupille Selected Research

Neoplasms (Cancer)

4/2022Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials.
4/2020High pre-treatment neutrophil-to-lymphocyte ratio in patients with dermatomyositis/polymyositis predicts an increased risk of cancer.
1/2019Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials.
1/2018Application of Recommendations Regarding the Use of Subcutaneous Tumor Necrosis Factor Inhibitors in Spondyloarthritis by Rheumatologists in Daily Practice.
5/2009Abatacept therapy and safety management.
1/2009[Monoclonals antibodies: a recent and major therapeutic advance].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philippe Goupille Research Topics

Disease

28Rheumatoid Arthritis
07/2022 - 01/2004
12Ankylosing Spondylitis
01/2022 - 04/2006
11Axial Spondyloarthritis
07/2022 - 03/2012
11Psoriatic Arthritis
07/2022 - 12/2005
11Inflammation (Inflammations)
01/2021 - 07/2006
9Pain (Aches)
01/2021 - 07/2002
6Neoplasms (Cancer)
04/2022 - 01/2009
5Arthritis (Polyarthritis)
09/2021 - 10/2007
5Spondylarthropathies
11/2012 - 10/2006
4Rheumatic Diseases (Rheumatism)
05/2021 - 06/2011
4Osteoarthritis
01/2021 - 07/2005
4Crohn Disease (Crohn's Disease)
01/2019 - 04/2006
3Infections
04/2022 - 01/2019
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 01/2019
3Necrosis
07/2014 - 01/2012
3Knee Osteoarthritis
07/2014 - 07/2005
3Juvenile Arthritis (Juvenile Idiopathic Arthritis)
03/2012 - 01/2009
3Intervertebral Disc Displacement (Herniated Disc)
12/2007 - 03/2006
3Sciatica (Sciatic Neuralgia)
12/2007 - 03/2006
2Tuberculosis (Tuberculoses)
04/2022 - 07/2006
2Lipomatosis
01/2022 - 01/2006
2Symptom Flare Up
10/2021 - 06/2003
2COVID-19
10/2021 - 10/2020
2Ulcerative Colitis
01/2019 - 10/2016
2Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 05/2009
2Autoimmune Diseases (Autoimmune Disease)
03/2012 - 05/2009
2Joint Diseases (Joint Disease)
03/2012 - 06/2010
2Radiculopathy (Radiculopathy, Cervical)
08/2007 - 03/2006
1Oral Candidiasis (Thrush)
04/2022
1Opportunistic Infections (Opportunistic Infection)
04/2022
1Herpes Zoster
04/2022
1Nasopharyngitis
04/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
04/2022
1Anemia
04/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Myocardial Infarction
01/2022
1Gout
09/2021
1Gouty Arthritis
09/2021
1Synovitis
09/2021
1Lymphoma (Lymphomas)
01/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2020
1Colonic Neoplasms (Colon Cancer)
01/2020
1Spondylarthritis (Spinal Arthritis)
01/2020
1Breast Neoplasms (Breast Cancer)
12/2019
1Hip Osteoarthritis (Coxarthrosis)
01/2019
1Injection Site Reaction
01/2019
1Candidiasis (Moniliasis)
01/2019
1Hypersensitivity (Allergy)
01/2019
1Osteoporotic Fractures
11/2017

Drug/Important Bio-Agent (IBA)

15Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 12/2005
12Biological ProductsIBA
07/2022 - 04/2010
12Infliximab (Remicade)FDA Link
11/2021 - 04/2006
10Pharmaceutical PreparationsIBA
01/2022 - 06/2003
8Adalimumab (Humira)FDA Link
04/2022 - 01/2009
8Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 07/2006
7Monoclonal AntibodiesIBA
11/2021 - 01/2009
6Antirheumatic Agents (DMARD)IBA
04/2022 - 10/2007
6Tumor Necrosis Factor InhibitorsIBA
11/2021 - 01/2009
6AntibodiesIBA
01/2020 - 01/2006
4C-Reactive ProteinIBA
09/2021 - 11/2003
4ametantrone (HAQ)IBA
10/2013 - 11/2003
3golimumabFDA Link
07/2022 - 12/2020
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2021 - 06/2003
3Rheumatoid FactorIBA
01/2021 - 10/2013
3tocilizumab (atlizumab)FDA Link
01/2021 - 06/2010
3Adrenal Cortex Hormones (Corticosteroids)IBA
10/2020 - 07/2014
3Rituximab (Mabthera)FDA Link
12/2019 - 06/2013
3Anti-Citrullinated Protein AntibodiesIBA
08/2014 - 06/2013
3SteroidsIBA
07/2014 - 10/2007
3GlucocorticoidsIBA
12/2007 - 07/2006
2Creatine Kinase (Creatine Phosphokinase)IBA
04/2022 - 04/2020
2Janus Kinase InhibitorsIBA
04/2022 - 10/2019
2Interleukin-17 (Interleukin 17)IBA
01/2022 - 01/2020
2secukinumabIBA
01/2022 - 01/2020
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
09/2021 - 01/2007
2Analgesics (Analgesic Drugs)IBA
01/2021 - 07/2002
2ixekizumabIBA
10/2020 - 01/2019
2AutoantibodiesIBA
04/2020 - 01/2006
2Biomarkers (Surrogate Marker)IBA
10/2016 - 06/2011
2Acute-Phase Proteins (Acute-Phase Protein)IBA
08/2014 - 03/2012
2cyclic citrullinated peptideIBA
10/2013 - 01/2006
2Abatacept (Orencia)FDA Link
03/2012 - 05/2009
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2008 - 07/2006
2Interleukin-1 (Interleukin 1)IBA
01/2007 - 07/2005
1upadacitinibIBA
04/2022
1vinyltriethoxysilane (VTES)IBA
04/2022
1Immunomodulating AgentsIBA
10/2021
1Calcium PyrophosphateIBA
09/2021
1Interleukin-1beta (Interleukin 1 beta)IBA
09/2021
1Uric Acid (Urate)IBA
09/2021
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2021
1Certolizumab PegolFDA Link
01/2020
1Trastuzumab (Herceptin)FDA Link
12/2019
14-hexyloxyaniline (HOA)IBA
01/2019

Therapy/Procedure

21Therapeutics
07/2022 - 06/2003
5Biological Therapy
01/2022 - 12/2005
3Contraindications
09/2021 - 05/2009
2Conservative Treatment
07/2014 - 03/2006
2Intra-Articular Injections
12/2009 - 07/2005
1Colectomy
01/2022